These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

559 related articles for article (PubMed ID: 28527674)

  • 1. Analysis of full coding sequence of the TP53 gene in invasive vulvar cancers: Implications for therapy.
    Kashofer K; Regauer S
    Gynecol Oncol; 2017 Aug; 146(2):314-318. PubMed ID: 28527674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of TP53 mutations in vulvar carcinomas.
    Choschzick M; Hantaredja W; Tennstedt P; Gieseking F; Wölber L; Simon R
    Int J Gynecol Pathol; 2011 Sep; 30(5):497-504. PubMed ID: 21804386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 mutations and clonality in vulvar carcinomas and squamous hyperplasias: evidence suggesting that squamous hyperplasias do not serve as direct precursors of human papillomavirus-negative vulvar carcinomas.
    Kim YT; Thomas NF; Kessis TD; Wilkinson EJ; Hedrick L; Cho KR
    Hum Pathol; 1996 Apr; 27(4):389-95. PubMed ID: 8617483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time series analysis of TP53 gene mutations in recurrent HPV-negative vulvar squamous cell carcinoma.
    Regauer S; Kashofer K; Reich O
    Mod Pathol; 2019 Mar; 32(3):415-422. PubMed ID: 30291345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presence and persistence of HPV infection and p53 mutation in cancer of the cervix uteri and the vulva.
    Milde-Langosch K; Albrecht K; Joram S; Schlechte H; Giessing M; Löning T
    Int J Cancer; 1995 Nov; 63(5):639-45. PubMed ID: 7591279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression or mutation of TP53 and HPV in vulvar cancer.
    Ngan HY; Cheung AN; Liu SS; Yip PS; Tsao SW
    Eur J Cancer; 1999 Mar; 35(3):481-4. PubMed ID: 10448303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.
    Kashofer K; Winter E; Halbwedl I; Thueringer A; Kreiner M; Sauer S; Regauer S
    Mod Pathol; 2017 Jul; 30(7):1013-1020. PubMed ID: 28387325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative analysis of human papillomavirus types 16 and 18 and expression of p53 gene and Ki-67 in cervical, vaginal, and vulvar carcinomas.
    Koyamatsu Y; Yokoyama M; Nakao Y; Fukuda K; Saito T; Matsukuma K; Iwasaka T
    Gynecol Oncol; 2003 Sep; 90(3):547-51. PubMed ID: 13678722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains.
    Ordi O; Saco A; Peñuelas N; Blanco-Irazuegui O; Pino MD; Carreras-Dieguez N; Marimon L; Rodrigo-Calvo MT; Morató A; Sisuashvili L; Bustamante M; Cruells A; Darecka K; Vega N; Alós S; Trias I; Fusté P; Parra G; Gut M; Munmany M; Torné A; Jares P; Rakislova N
    Mod Pathol; 2024 Oct; 37(10):100574. PubMed ID: 39089654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV detection and genotyping in vulvar squamous cell carcinoma in northern Thailand.
    Siriaunkgul S; Settakorn J; Sukpan K; Srisomboon J; Utaipat U; Lekawanvijit S; Khunamornpong S
    Asian Pac J Cancer Prev; 2014; 15(8):3773-8. PubMed ID: 24870792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic changes during the multistage pathogenesis of human papillomavirus positive and negative vulvar carcinomas.
    Flowers LC; Wistuba II; Scurry J; Muller CY; Ashfaq R; Miller DS; Minna JD; Gazdar AF
    J Soc Gynecol Investig; 1999; 6(4):213-21. PubMed ID: 10486784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High numbers of activated helper T cells are associated with better clinical outcome in early stage vulvar cancer, irrespective of HPV or p53 status.
    Kortekaas KE; Santegoets SJ; Abdulrahman Z; van Ham VJ; van der Tol M; Ehsan I; van Doorn HC; Bosse T; van Poelgeest MIE; van der Burg SH
    J Immunother Cancer; 2019 Sep; 7(1):236. PubMed ID: 31481117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated vulvar intraepithelial neoplasia contains Tp53 mutations and is genetically linked to vulvar squamous cell carcinoma.
    Pinto AP; Miron A; Yassin Y; Monte N; Woo TY; Mehra KK; Medeiros F; Crum CP
    Mod Pathol; 2010 Mar; 23(3):404-12. PubMed ID: 20062014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence of oncogenic KRAS mutations in squamous cell carcinomas of the anogenital tract and head and neck region independent of human papillomavirus and p16(INK4a) status.
    Prigge ES; Urban K; Stiegler S; Müller M; Kloor M; Mai S; Ottstadt M; Lohr F; Wenz F; Wagner S; Wittekindt C; Klussmann JP; Hampl M; von Knebel Doeberitz M; Reuschenbach M
    Hum Pathol; 2014 Nov; 45(11):2347-54. PubMed ID: 25257576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of HPV 16, 18 and p53 immunohistochemical staining in tumor tissue of Israeli Jewish women with cervical and vulvar neoplasia.
    Menczer J; Fintsi Y; Arbel-Alon S; Tell L; Friedman E; Jackman A; Sherman L
    Eur J Gynaecol Oncol; 2000; 21(1):30-4. PubMed ID: 10726615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome.
    Tessier-Cloutier B; Pors J; Thompson E; Ho J; Prentice L; McConechy M; Aguirre-Hernandez R; Miller R; Leung S; Proctor L; McAlpine JN; Huntsman DG; Gilks CB; Hoang LN
    Mod Pathol; 2021 Feb; 34(2):508-518. PubMed ID: 32792599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas.
    Loeb KR; Asgari MM; Hawes SE; Feng Q; Stern JE; Jiang M; Argenyi ZB; de Villiers EM; Kiviat NB
    PLoS One; 2012; 7(4):e34422. PubMed ID: 22545084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Kortekaas KE; Bastiaannet E; van Doorn HC; de Vos van Steenwijk PJ; Ewing-Graham PC; Creutzberg CL; Akdeniz K; Nooij LS; van der Burg SH; Bosse T; van Poelgeest MIE
    Gynecol Oncol; 2020 Dec; 159(3):649-656. PubMed ID: 32972785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
    Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
    Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 alterations and HPV infections are common in oral SCC: p53 gene mutations correlate with the absence of HPV 16-E6 DNA.
    Penhallow J; Steingrimsdottir H; Elamin F; Warnakulasuriya S; Farzaneh F; Johnson N; Tavassoli M
    Int J Oncol; 1998 Jan; 12(1):59-68. PubMed ID: 9454887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.